Company Overview - Victory Square Technologies Inc. is a venture builder providing investors access to a diverse portfolio of next-generation technology companies [2][23] - The company operates a business model focused on buying, building, and investing in early-stage tech companies, with a commitment to support them for up to 48 months before they can stand on their own [24][26] Financial Performance - For the first half of 2025, adjusted revenue reached $13.87 million, a 27% increase from $10.97 million in the first half of 2024 [7] - Q2 2025 revenue was $5.38 million, compared to $4.43 million in Q2 2024, marking a 21% year-over-year growth [7] - Adjusted EBITDA for the first half of 2025 was $463 thousand, a significant improvement from a loss of $1.59 million in the first half of 2024 [7] Portfolio Highlights - Victory Square maintains over 25 portfolio companies across sectors including digital health, AI, gaming, climate tech, and pet wellness [5][6] - Hydreight Technologies, a key portfolio company, reported a six-month adjusted revenue of $13.9 million, reflecting a 33% year-over-year growth and achieved its third consecutive profitable quarter [6][8] - Insu Therapeutics is developing a patent-pending oral insulin tablet, with early preclinical trials showing promising results [10][11] Strategic Initiatives - The company is exploring share buybacks to reduce net asset value (NAV) discount and enhance shareholder value [6][16] - Pawsible Ventures, another portfolio company, is focused on pet wellness and telehealth solutions, with plans to launch a fund and incubator program in fall 2025 [12][15] Industry Context - The global diabetes therapeutics market is projected to grow to $118 billion by 2032, with over 500 million people currently living with diabetes [13] - The global pet care market is expected to reach $368 billion by 2030, indicating significant growth potential in the pet wellness sector [14] Future Outlook - The company aims to continue supporting Hydreight's growth, advance Insu Therapeutics towards regulatory milestones, and launch Pawsible Ventures' fund and incubator program [20][21] - Upcoming investor conferences will feature Victory Square and its portfolio companies, providing opportunities for engagement with investors [21]